Pacific Biosciences (PACB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2011 | 12-2010 | 09-2010 | 06-2010 | 03-2010 | |
| Sales | 270 | 280 | 220 | 629 | 545 |
| Gross Profit | 270 | 280 | 220 | 629 | 545 |
| Operating Expenses | 35,237 | 36,869 | 40,916 | 33,304 | 30,819 |
| Operating Income | -34,967 | -36,589 | -40,696 | -32,675 | -30,274 |
| Other Income | 158 | 170 | -12 | -39 | -51 |
| Pre-tax Income | -34,809 | -36,419 | -40,708 | -32,714 | -30,325 |
| Net Income Continuous | -34,809 | -36,419 | -40,708 | -32,714 | -30,325 |
| Net Income | $-34,809 | $-36,419 | $-40,708 | $-32,714 | $-30,325 |
| EPS Basic Total Ops | -0.66 | 125.77 | -39.70 | -51.20 | -48.97 |
| EPS Basic Continuous Ops | -0.66 | 125.80 | -39.72 | -51.20 | -48.99 |
| EPS Diluted Total Ops | -0.66 | 125.77 | -39.70 | -51.20 | -48.97 |
| EPS Diluted Continuous Ops | -0.66 | 125.80 | -39.72 | -51.20 | -48.99 |
| EBITDA(a) | $-33,499 | $-35,132 | $-39,253 | $-31,466 | $-29,223 |